8-K//Current report
Molecular Insight Pharmaceuticals, Inc. 8-K
Accession 0001193125-11-126307
CIK 0001340752operating
Filed
May 3, 8:00 PM ET
Accepted
May 4, 5:06 PM ET
Size
776.7 KB
Accession
0001193125-11-126307
Documents
- 8-Kd8k.htmPrimary
FORM 8-K
- EX-10.1dex101.htm
SENIOR SECURED SUPER PRIORITY DEBTOR-IN-POSSESSION CREDIT AGREEMENT
- EX-10.2dex102.htm
SECURITY AGREEMENT BETWEEN MOLECULAR INSIGHT PHARMACEUTICALS, INC. AND NEXBANK
- EX-99.1dex991.htm
PRESS RELEASE OF MOLECULAR INSIGHT PHARMACEUTICALS, INC
- GRAPHICg183279g33w44.jpg
GRAPHIC
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0001340752
Filing Metadata
- Form type
- 8-K
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 5:06 PM ET
- Size
- 776.7 KB